KIT and ovarian cancer: Pasto et al. showed that CD44+CD117+ ovarian cancer stem cells isolated from epithelial ovarian cancer patients showed both a high glucose uptake and a high OXPHOS phenotype (active metabolic phenotype), which was associated with their increased ability to survive under glucose free conditions21.